Canaccord Genuity Reiterates a 'Buy' on Imris Inc. (IMRS); Q1 Bookings Help Validate Funnel
Tweet
Share
E-mailGet Alerts IMRS Hot Sheet
Price: $0.02 --0%
Rating Summary:
3 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Rating Summary:
3 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Join SI Premium – FREE
Canaccord Genuity reiterates a 'Buy' on Imris Inc. (NASDAQ: IMRS) price target of $4.50.
Analyst, Jason R. Mills, said, "Q4 bookings ($8M) plus the bookings in the first two months of 2012 ($22M) provide much-needed credibility to IMRS’ assertion that its customer sales funnel is real and potentially robust. IMRS has already booked nearly one-third of our 2012E ($68M) in the first 60 days of the year. Another bookings bolus like this could move the stock to our $4.50 PT (nearly 2x recent trading levels). We continue to believe the VISIUS surgical arenas offer a significant value proposition to hospitals and believe penetration can increase 2-3x over the long term."
For an analyst ratings summary and ratings history on Imris Inc. click here. For more ratings news on Imris Inc. click here.
Shares of Imris Inc. closed at $2.70 yesterday.
Analyst, Jason R. Mills, said, "Q4 bookings ($8M) plus the bookings in the first two months of 2012 ($22M) provide much-needed credibility to IMRS’ assertion that its customer sales funnel is real and potentially robust. IMRS has already booked nearly one-third of our 2012E ($68M) in the first 60 days of the year. Another bookings bolus like this could move the stock to our $4.50 PT (nearly 2x recent trading levels). We continue to believe the VISIUS surgical arenas offer a significant value proposition to hospitals and believe penetration can increase 2-3x over the long term."
For an analyst ratings summary and ratings history on Imris Inc. click here. For more ratings news on Imris Inc. click here.
Shares of Imris Inc. closed at $2.70 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- META to capture largest share of users, SNAP to benefit from ad budget shifts - Canaccord Genuity weighs in on TikTok ban
- Can Boeing overcome struggles? Analysts see 'path back to normal' after earnings
- Teradyne (TER) PT Raised to $125 at TD Cowen
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS ViewSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
